NCT03961945View on ClinicalTrials.gov

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

1,550

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

January 2, 2026

Study Completion Date

January 2, 2027

Conditions
Barrett EsophagusEsophageal Adenocarcinoma
Interventions
DEVICE

Sponge Capsule

Subjects will swallow sponge capsule and esophageal cells will be collected on deployed sponge.

Trial Locations (9)

11040

COMPLETED

Northwell Health, New Hyde Park

32224

COMPLETED

Mayo Clinic Jacksonville, Jacksonville

54601

WITHDRAWN

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

RECRUITING

Mayo Clinic Health System-Eau Claire, Eau Claire

55905

RECRUITING

Mayo Clinic Rochester, Rochester

55912

RECRUITING

Mayo Clinic Health Systems - Austin, Austin

56001

COMPLETED

Mayo Clinic Health Systems - Mankato, Mankato

75246

COMPLETED

Baylor Scott & White Research Institute, Dallas

85259

COMPLETED

Mayo Clinic Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER